Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
89.43%
-
Total 13F principal
-
$74,572,353
-
Principal change
-
-$4,166,765
-
Total reported market value
-
$66,642,519
-
Number of holders
-
22
-
Value change
-
-$4,602,298
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q1 2016
As of 31 Mar 2016,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
22 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$74,572,353
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, FMR LLC, ZAZOVE ASSOCIATES LLC, Guardian Life Insurance Co of America, PERCEPTIVE ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, Allianz Asset Management AG, DEUTSCHE BANK AG\, Visium Asset Management, LP, and GABELLI FUNDS LLC.
This page lists
22
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.